Home » Topics » BioWorld Science

BioWorld Science
RSS

Vertex Pharmaceuticals patents CFTR potentiators

April 29, 2022

University of California discloses new PRMT8 inhibitors

April 29, 2022

ProfoundBio presents novel ADCs for cancer treatment

April 29, 2022

Study finds targets of T-cell response in multiple sclerosis

April 28, 2022

Allogeneic NK-cell therapy CAT-179 useful for controlling HER2-positive tumors

April 28, 2022

AT-0174 IDO/TDO dual inhibitor shows promise for treating platinum-resistant NSCLC

April 28, 2022

Herantis reports blood-brain barrier penetration data with HER-096 in dogs

April 28, 2022

Medy-Tox patents new BTK inhibitors

April 28, 2022

University of Texas System identifies CBP and/or p300 inhibitors

April 28, 2022

Humanwell Healthcare presents new P2X3 receptor antagonists

April 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.